参与者被随机分为认知行为组治疗（干预组，N = 67）或正念减压组（对照组，N = 58）。预先定义的结局是霍普金斯症状清单25所报告的焦虑和抑郁症状，以及12个月随访时情绪调节量表中的的一般情绪调节困难程度。
参与者报告的焦虑和抑郁症状有所减轻，各组之间无差异（干预组：系数：-0.17，P = 0.009；对照组：系数：-0.13，P = 0.036）。两组在随访12个月后，情绪调节量表的得分均有少量但统计学显著的降低（干预组：系数：− 0.47，P <0.001；对照组：系数：−0.34，P <0.001）。
Intimate partner violence constitutes a serious health problem worldwide. To date the evidence is sparse on whether intimate partner violence group interventions could improve mental health outcomes among perpetrators and their partners.
To compare the effectiveness of nurse-led cognitive-behavioural group therapy vs mindfulness-based stress reduction group therapy in improving reported mental health outcomes and emotion regulation at 12 months’ follow-up amongst perpetrators who voluntarily seek help for violence in intimate partnerships.
A randomized controlled trial.
A total of 125 persons at an outpatient service run by a University Hospital in Norway for men who perpetrate intimate partner violence were enrolled in the study. Methods: The participants were randomly assigned to cognitive-behavioural group therapy (intervention group, N = 67) or mindfulness-based stress reduction group therapy (comparator group, N = 58). The pre-defined outcomes were symptoms of anxiety and depression as reported by the Hopkins Symptom Checklist 25 and general emotion regulation as reported by Difficulties in Emotion Regulation Scale at 12 months’ follow-up. Results: A reduction of symptoms of anxiety and depression was reported, with no between groups differences (intervention group: coefficient: − 0.17, P = 0.009; comparator group: coefficient: − 0.13, P = 0.036). Both groups had a small but statistically significant reduction in the Difficulties in Emotion Regulation Scale scores at 12 months’ follow-up (intervention group: coefficient: − 0.47, P = <0.001; comparator group: coefficient: − 0. 34, P = <0.001).
Even though there was reduction in symptoms in both groups at 12 months’ follow-up with no between-group differences, the total symptom scores remained high in both groups.
clinicaltrials.gov Identifier: NCT01653860.